Unlearn AI is a technology company revolutionizing the field of medicine through the application of artificial intelligence (AI) to clinical trials. The company develops generative AI solutions that create digital twins of individual trial participants, enabling smaller and more efficient clinical trials. This innovative approach aims to eliminate the traditional trial-and-error methods in medicine, allowing for faster development of effective therapies that can reach patients sooner. Founded in 2017 by leading machine learning scientists, Unlearn AI emphasizes a collaborative, team-oriented culture with core values such as ambition, discipline, and receptiveness to new ideas. With its headquarters in San Francisco and a growing team, Unlearn AI seeks individuals who are eager to contribute to its mission of redefining how AI is leveraged in healthcare.